Pioneering study shows promising results for cognitive treatment in Down syndrome
Uniunea Europeana
IMIM (Hospital del Mar Medical Research Institute) Dec 17 2024 The ICOD (Improving Condition in Down syndrome) project, a pioneering study in addressing the cognitive difficulties associated with Down syndrome, has demonstrated the safety of treatment with the molecule AEF0217, developed by the French biotech Aelis Farma, as well as its effectiveness in improving cognitive function in these people. The study was led by the Research Institute of the Hospital del Mar. This phase of the trial (
din zilele anterioare